Baytril 5% Iny
DESCRIPTION
Baytril® 5% Injectable Solution
Composition
1 ml injectable solution contains 50 mg Enrofloxacin.
Indications for use
Enrofloxacin is a synthetic antiinfective of the fluoroquinolone class.
Baytril® 5% injectable solution is indicated for the therapy of infectious diseases in cattle where clinical experience, supported where possible by sensitivity testing of the causal organisms, indicates Enrofloxacin as the drug of choice.
Respiratory and enteric diseases (Pasteurellosis, Mycoplasmosis, Colibacillosis, Colisepticaemia and secondary bacterial infections in crowding disease), Mastitis caused by susceptible microorganisms.
Baytril® is effective against the following microorganisms: Mycoplasma spp., E. coli, Salmonella spp.,Haemophilus spp., Pasteurella spp., Klebsiella spp., Proteus spp., Vibrio parahaemolyticusand Staphylococcus aureus.
Route of administration
For subcutaneous, intramuscular and intravenous administration.
Not more then 10ml should be administered at one i.m. or s.c. injection site.
Dosage
The dose rate is 2.5 mg Enrofloxacin/ kg bw, (= 5 ml Baytril® 5% inj. solution / 100 kg bw) For complicated respiratory disease this rate may be doubled to 5 mg / kg bw ( = 10 ml Baytril® 5% inj. solution / 100 kg bw).
Treatment interval
24 hours
Duration of treatment
3 – 5 days
Withdrawal period
Established for edible tissues and milk according to national regulations
Baytril 5% Iny
DESCRIPTION
Baytril® 5% Injectable Solution
Composition
1 ml injectable solution contains 50 mg Enrofloxacin.
Indications for use
Enrofloxacin is a synthetic antiinfective of the fluoroquinolone class.
Baytril® 5% injectable solution is indicated for the therapy of infectious diseases in cattle where clinical experience, supported where possible by sensitivity testing of the causal organisms, indicates Enrofloxacin as the drug of choice.
Respiratory and enteric diseases (Pasteurellosis, Mycoplasmosis, Colibacillosis, Colisepticaemia and secondary bacterial infections in crowding disease), Mastitis caused by susceptible microorganisms.
Baytril® is effective against the following microorganisms: Mycoplasma spp., E. coli, Salmonella spp.,Haemophilus spp., Pasteurella spp., Klebsiella spp., Proteus spp., Vibrio parahaemolyticusand Staphylococcus aureus.
Route of administration
For subcutaneous, intramuscular and intravenous administration.
Not more then 10ml should be administered at one i.m. or s.c. injection site.
Dosage
The dose rate is 2.5 mg Enrofloxacin/ kg bw, (= 5 ml Baytril® 5% inj. solution / 100 kg bw) For complicated respiratory disease this rate may be doubled to 5 mg / kg bw ( = 10 ml Baytril® 5% inj. solution / 100 kg bw).
Treatment interval
24 hours
Duration of treatment
3 – 5 days
Withdrawal period
Established for edible tissues and milk according to national regulations
Español
Portugués
